New hope for Tough-to-Treat myeloma: experimental drug SG2918 enters human trials
NCT ID NCT07454187
First seen Mar 11, 2026 · Last updated May 09, 2026 · Updated 8 times
Summary
This early-stage study tests a new drug called SG2918 in 40 people whose multiple myeloma has returned or not responded to prior treatments. The main goal is to check the drug's safety and how well the body tolerates it. Researchers will also measure how the drug moves through the body and look for early signs that it might help control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henan Cancer Hospital
Zhengzhou, Henan, 450000, China
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
The First Affiliated Hospital Of Soochow University
Suzhou, Jiangsu, 215006, China
Contact Email: •••••@•••••
-
The Second Affiliated Hospital Of Xi an Jiaotong University (Xibei Hospital)
Xi’an, Shanxi, 710000, China
Contact Email: •••••@•••••
-
The Second Affiliated Hospital Zhejiang University School Of Medicine
Hangzhou, Zhejiang, 310056, China
Conditions
Explore the condition pages connected to this study.